Statol

Quick links to important sections

Statol

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Statol

What is Statol? Identity and Pharmacological Class

Property Description
Active Ingredient Atorvastatin calcium
Form Film-coated tablet (Oral)
Pharmacological Class HMG-CoA Reductase Inhibitor (Statin)
General Purpose Lipid-lowering agent (Hypolipidemic)
Origin Synthetic compound
Prescription Status Prescription-Only (Rx)

Statol is an oral, prescription-only medication whose active component is Atorvastatin calcium (INN), a synthetic compound designed for systemic action. The drug belongs to the class of HMG-CoA Reductase Inhibitors, commonly known as statins.

This classification, clinically recognized across major medical guidelines, positions Statol as an essential lipid-lowering agent (hypolipidemic agent) aimed at managing blood lipids. The medicine is supplied as a convenient film-coated tablet and is distinguished as a high-intensity statin at specific doses, demonstrating a pronounced effect in significantly reducing Low-Density Lipoprotein Cholesterol (LDL-C).

Composition and General Therapeutic Purpose

The core of Statol's composition is the single active substance, Atorvastatin, which is a high-efficacy synthetic molecule. While the original brand-name product for Atorvastatin is Lipitor, Statol is a common prescription-only generic alternative often manufactured by companies such as Sun Pharmaceutical for various global markets.

The overarching therapeutic purpose of Statol is to manage conditions like hypercholesterolemia and overall dyslipidemia by addressing cholesterol production directly. This medication reduces the levels of LDL-C ("bad cholesterol") and triglycerides, while providing the general benefit of increasing High-Density Lipoprotein Cholesterol (HDL-C) ("good cholesterol"). This collective modification is central to the drug's role in promoting a healthier balance in the lipid status of adult patients and specific pediatric groups.

Regulatory References

  1. Atorvastatin Drug Information (MedlinePlus NIH)

What side effects are possible with Statol?

Possible Side Effects and Safety Information

The safety profile for Statol is characterized by a set of serious warnings and a spectrum of common to rare adverse reactions documented in regulatory sources.

Serious and Clinically Significant Risks

Official labeling emphasizes the potential for Myopathy and Rhabdomyolysis, which involves severe muscle damage that can lead to acute kidney injury and is a rare, life-threatening risk, with incidence increasing at higher doses and in specific populations. Patients are advised to report unexplained muscle pain, tenderness, or weakness, especially if accompanied by fever or malaise. Additionally, Statol may cause Hepatic Dysfunction; persistent elevations in liver enzymes have occurred, and rare cases of fatal and non-fatal hepatic failure are reported.

Common Adverse Reactions

The most frequent adverse reactions reported in clinical trials (incidence ge 2%) typically involve the nervous, musculoskeletal, and gastrointestinal systems. These commonly include:

  • Headache
  • Myalgia (muscle pain)
  • Nausea and Vomiting
  • Constipation or Diarrhea
  • Asthenia (weakness)
  • Dizziness and Arthralgia (joint pain)

Population and Concomitant Use Warnings

Safety information specifies that certain populations are at increased risk for adverse effects, including elderly patients (ge 65 years old) and those with uncontrolled hypothyroidism or renal impairment. Statol is also contraindicated in pregnancy and lactation, as it may cause fetal harm and is not recommended for breastfeeding mothers. Furthermore, the risk of muscle damage is significantly increased when Statol is co-administered with certain other medicines, particularly strong CYP3A4 inhibitors and specific immunosuppressants. Liver enzyme testing is typically performed prior to initiating therapy and thereafter as clinically indicated.

Overdose and Emergency Response

Overdose and When to Seek Help

The official guidance for Statol (Atorvastatin) overdosage is based on mandatory emergency action and established limitations regarding procedural intervention, as documented in government regulatory sources.

Official Regulatory Statement Focus
No specific symptoms or unique clinical manifestations are documented following acute overdosage that differentiate it from general adverse events. Documented Presentations
No specific antidote is known for Atorvastatin. Antidote Information
Symptomatic and supportive treatment must be instituted. Supportive Management

Regulatory authorities strictly mandate that individuals seek immediate medical attention for any suspected overdosage. This required action must be followed immediately by contacting emergency services or a national Poison Control center.

The official overdose profile requires continuous clinical monitoring due to the lack of a specific antidote. A critical constraint on treatment, as noted in prescribing information, is that hemodialysis is not expected to significantly enhance clearance of the active substance. This is due to the extensive plasma protein binding of Atorvastatin, which limits drug removal via standard dialysis procedures. Management is therefore focused entirely on general systemic support and observation.

Therapeutic Uses of Statol

What Statol Treats: Main Uses and Benefits

Statol is applied across domains where additional symptomatic support is needed. It is relevant in contexts that involve temporary assistance to support patient comfort and functional capacity during acute or heightened symptomatic episodes.

It is generally used in situations involving certain distressing symptoms, including those associated with acute or episodic changes, severe pain, or conditions marked by increased physiological stress. The medication may assist with symptomatic relief, which can help ease the overall symptom load and supports patients during difficult episodes.

Relevant Therapeutic Domains

Statol is applicable for easing periods of heightened symptomatic discomfort and providing support for conditions with episodic or fluctuating symptom patterns that may create temporary functional strain. It helps address symptom clusters that can become intense or disruptive, potentially interfering with routine daily functioning.

“The purpose of this management may be to offer symptomatic relief that helps patients cope more steadily during difficult episodes of discomfort.”

  • Quick Fact: Support for Acute Symptomatic Episodes Statol is often used when symptoms intensify and supportive relief is needed.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Statol — Official Regulatory Information

Eligibility Status Description (as per Regulatory Labeling)
Contraindicated Populations Active liver disease, including unexplained persistent elevations of hepatic transaminases. Pregnancy and Lactation (Breastfeeding). Known hypersensitivity to atorvastatin or any component of the medication.
Adults Eligible for use under standard labeled conditions for lipid-lowering therapy.
Pediatric Patients Approved for use in children 10 years and older with specific inherited high cholesterol conditions, such as Heterozygous or Homozygous Familial Hypercholesterolemia. Use is not recommended for children under 10 years of age.
Conditional Use Patients with a history of liver disease or who consume substantial alcohol require caution. Individuals with predisposing factors for muscle disorders, such as uncontrolled hypothyroidism or renal impairment, are eligible but require special consideration due to increased risk.

Official regulatory documents define eligibility primarily by prohibiting use in populations where the risk is absolute, such as pregnant women or those with active liver disease. Furthermore, eligibility is restricted by minimum age and is conditional on the presence of certain comorbidities, which regulatory agencies classify as risk factors requiring cautious monitoring, not as absolute exclusions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions involving Statol (Butorphanol) are primarily related to its effects on the central nervous system and its mixed opioid agonist/antagonist activity, as documented in authoritative regulatory sources.


Pharmacodynamic Interactions and Restrictions

Interacting Product Category Official Interaction Constraint Severity Classification
CNS Depressants (e.g., Benzodiazepines, Muscle Relaxants, General Anesthetics, Alcohol) Co-administration may result in additive CNS depression, increasing the risk of respiratory depression and profound sedation. Serious/Potentially Fatal
Opioid Agonists Administration to physically dependent patients may precipitate acute opioid withdrawal due to Statol’s antagonist activity. Clinically Significant
Serotonergic Drugs (e.g., SSRIs, SNRIs) Potential for serotonin syndrome; requires frequent evaluation, particularly upon treatment initiation. Significant

Other Regulatory Considerations

The official profile notes that hepatic impairment significantly alters the drug's elimination, leading to a greater systemic exposure and necessitating cautious initial dosing in this population. Concomitant use with alcohol is strongly discouraged due to the risk of additive CNS effects. Certain opioid antagonists are contraindicated in specific patient contexts, and for some, an opioid-free interval (up to 14 days) is advised before administration of the antagonist.

Mechanism of Action

How Statol Works

Statol operates by precisely engaging specific molecular mechanisms to influence the systemic activity pattern within physiological pathways. The drug's action is characterized by its influence across several distinct mechanistic domains, ultimately resulting in subsequent physiological adjustments.


Modulation of Receptor-Mediated Signaling

Statol acts as a selective antagonist within systems where specific neurotransmitters or mediators dominate. This involves binding competitively to G-protein coupled receptors (GPCRs) or enzyme active sites, thereby preventing the natural ligand from initiating downstream signaling. By suppressing these early molecular steps, Statol modifies the initial signal magnitude, which is crucial for shaping systemic physiological outcomes and modifying the resulting activity of intracellular mediators.


Engagement of Dysregulated Processes

The drug engages mechanisms that influence overactive or dysregulated signaling cascades, particularly those characterized by excessive pathway activation. This action modifies the sequence of intracellular phosphorylation and second messenger signaling, contributing to a shift in the pathway's activation status and influencing the overall rate of activation within targeted physiological systems.


Influence on Feedback Regulation

Statol also affects the internal feedback regulation within signaling networks. By altering the sensitivity or activity of key pathway components, the drug imposes a negative or positive regulatory influence, thereby supporting the modulation of processes driven by distinct signaling patterns at a system level.

Dosage and Administration Information

How to Use Statol — Official Administration Guidelines

The following guidelines outline the standardized administration of Statol (Atorvastatin), focusing strictly on standardized instructions.

Administration Scope Detail
Route of administration Oral (by mouth).
Dosing schedule Standard Adult Range: 10 mg to 80 mg once daily. The typical starting dose is 10 mg or 20 mg. The maximum recommended daily dose is 80 mg.
Timing in relation to meals The film-coated tablets can be administered with or without food and may be taken at any time of the day.
Preparation requirements Tablets are intended to be swallowed whole.
Age-group administration rules For pediatric patients (10–17 years) with Heterozygous Familial Hypercholesterolemia, the starting dose is 10 mg once daily, with a maximum dose of 20 mg daily. Dosage adjustment is not required for patients with renal impairment.
Missed-dose rules If a scheduled dose is missed, it should be skipped. The patient should continue with the regular schedule the following day, and the dose should not be doubled.
Special procedural conditions The medicine is administered as an adjunct to diet and non-pharmacological therapies. Dosage changes, based on clinical assessment, are typically made at a minimum of 4-week intervals.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral.
Frequency pattern Daily (Once Daily).
Basis of use Standardized therapeutic protocol.
Use-context constraints Must be used adjunctive to diet; maximum daily dose is 80 mg; minimum 4-week interval between dose adjustments.

Resulting Procedural Structure

Official step sequence:

  • Take the prescribed dose of Statol once daily.
  • Administer the dose orally (swallowing the film-coated tablet whole) at any time of the day.
  • The dose may be taken with or without food.
  • If a dose is missed, do not take a double dose; continue with the next scheduled dose.

Connection to the overall use protocol

The official instructions establish a structured, non-intermittent use protocol centered on a once-daily oral intake, defining it as chronic therapy. This regimen dictates adherence to strict dose limits (10 mg to 80 mg) and mandates a minimum 4-week period between any dose titrations, ensuring the administration is consistently aligned with the established therapeutic regimen.

Recent Clinical Evidence

Research evidence / Overview of studies for Statol

Evidence for Lipid Modification (Dyslipidemia)

Research examining Statol (Atorvastatin) in study settings related to high cholesterol and other lipid imbalances relies primarily on numerous Randomized Controlled Trials (RCTs). These trials monitor how the levels of specific fatty substances in the blood change over defined time intervals. The outcomes tracked focus mainly on shifts in key biomarkers: Low-Density Lipoprotein Cholesterol (LDL-C), Total Cholesterol, and Triglycerides. Studies monitored measured patterns related to LDL-C and Total Cholesterol changes, with those patterns observed to vary according to the dose used in the research.

Furthermore, the short-to-intermediate-term changes in biomarkers are well-characterized in the research, but data are still emerging regarding the sustained long-term patterns related to these specific lipid endpoints. The evidence is limited in fully characterizing the individual variability of patient responses.

Evidence for Cardiovascular Event Reduction

Beyond the measurement of cholesterol levels, large-scale, long-term clinical trials have been conducted that monitored Statol in research exploring major vascular events. These research scenarios included adults with established Coronary Heart Disease (secondary prevention), as well as adults with multiple risk factors but without previous heart events (primary prevention). Studies monitored the occurrence of a composite outcome known as Major Adverse Cardiovascular Events (MACE), which combines serious events such as non-fatal heart attack and stroke.

Long-Term Study Follow-up

Key clinical trials involved extended-duration data collection, with observation periods often ranging from two to five years. These large-scale, controlled research scenarios allowed studies to monitor outcomes related to long-term clinical status over significant time frames. The research provides insight into how the occurrence of events was observed in the populations throughout the study period. Follow-up durations were limited to the defined study endpoints, meaning that continuous data on patient status extending beyond five years are less commonly documented in large-scale interventional research.

Frequently Asked Questions (FAQ)

Common questions about Statol (FAQ)


Q: Is Statol addictive or habit-forming?

Statol, whose active ingredient is Atorvastatin, belongs to the statin drug class. Official regulatory documents do not classify this medicine as a controlled substance, and it is not documented as having addiction potential or being habit-forming.


Q: How quickly can someone expect Statol to start working?

According to official studies, reductions in key blood lipids, such as LDL-C (often called 'bad cholesterol'), are typically observed within two weeks after starting therapy. The maximum observed response is typically documented in studies as occurring within four weeks of beginning treatment.


Q: Does Statol need to be taken long-term?

Official product information indicates that Statol is generally intended for chronic administration as an adjunct to diet and other non-pharmacological therapies. Its purpose is the long-term management of elevated blood lipid levels, and continued intake is generally indicated for sustained effect.


Q: Can I take Statol if I also take a blood pressure medicine?

Statol is sometimes included in fixed-dose combination products with certain blood pressure medicines, indicating potential for co-administration. However, any specific combination is subject to medical review, as combined use is sometimes associated with necessary dosage adjustments.


Q: Does Statol interact with common pain relievers like ibuprofen?

Regulatory drug interaction screens often do not list a direct pharmacokinetic interaction between Statol (Atorvastatin) and common over-the-counter pain relievers such as ibuprofen. Disclosure of the use of all products, including pain relievers, to a healthcare professional is consistent with regulatory guidance.


Q: Can Statol affect my ability to drive or operate machinery?

Official safety information notes that Statol generally does not interfere with the ability to drive or operate machinery. However, since dizziness is listed as a possible side effect, if dizziness occurs, official regulatory information indicates that driving or operating machinery should be avoided.


Q: What happens if I miss a dose of Statol?

Official administration guidelines are clear: if a scheduled dose is skipped, the regulatory instruction specifies that patients should continue with the regular schedule the following day. The dose is not intended to be doubled to compensate for the skipped dose.


Q: Does the age of the patient affect how Statol works?

Studies noted that plasma concentrations of the drug can be higher in healthy elderly patients (age 65 years and older) compared to younger adults. Despite this difference in concentration, official data indicate that the overall desired reduction in LDL-C is observed to be the same regardless of the patient's age.


Q: Does Statol change its effect when taken with food?

The medicine is officially authorized to be administered with or without food. While the speed and amount of drug absorbed into the body might be different when taken with food, the overall lipid-lowering effect (efficacy) is similar in both scenarios.


Q: Can Statol be taken with alcohol?

Official regulatory information documents the importance of using caution regarding alcohol consumption. Drinking large quantities of alcohol during treatment may increase the potential risk of liver problems, which is one of the safety concerns associated with Statol.


Q: Does Statol have a Boxed Warning from the FDA?

Statol (Atorvastatin) does not currently carry a Boxed Warning in its official Food and Drug Administration (FDA) labeling. The Boxed Warning is the agency’s highest safety alert used to call attention to serious risks.


Q: Is Statol available as a generic drug?

Yes, Statol, which contains the active ingredient Atorvastatin, is widely available as a generic medication. This means it is not restricted to a single original brand name and may be manufactured by multiple companies after the patent expires.


Q: What is the difference between Statol and [Similar Drug Name]?

Statol's active component, Atorvastatin, belongs to a class of drugs called statins. Official sources classify the differences between various statins based primarily on their potency (how strongly they lower cholesterol) and their impact on different lipid levels in the blood.


Q: Is Statol the same as [Another Similar Drug Name]?

Statol is the active ingredient Atorvastatin. If the 'similar drug' contains the exact same active ingredient and salt form, it is considered a generic equivalent. If the other medicine contains a different active ingredient (e.g., Rosuvastatin or Simvastatin), it is a distinct, separate medication, even if it is in the same class.


Q: Is Statol considered a maintenance drug?

Yes, regulatory and official sources indicate that Statol is prescribed for the chronic management of elevated blood lipids. This classifies it as a maintenance drug, meaning its primary role is long-term therapeutic control of a chronic condition.


Q: Can Statol affect my sleep?

Official safety documents do not list common sleep disturbances, such as insomnia, among the most frequent adverse reactions for Statol. However, the occurrence of any adverse reaction is based on individual response.


Q: How long does Statol stay in your system after the last dose?

The mean elimination half-life for Statol (Atorvastatin) itself is approximately 14 hours. However, the half-life of its overall lipid-lowering activity is longer, ranging from 20 to 30 hours, due to the drug’s active byproducts (metabolites).


Q: Does Statol interact with vitamin supplements?

Official drug labels generally state that informing a healthcare provider about all concomitant products, including supplements and vitamins, aligns with general patient disclosure protocols. While labels may not list specific interactions, disclosure is recommended.


Q: Are there any specific foods that interact with Statol?

Yes, official regulatory warnings state that patients should limit or avoid drinking large quantities of grapefruit juice while undergoing treatment with Statol. Grapefruit juice can affect the drug’s metabolism, potentially increasing the amount of medicine in the body and raising the risk of side effects.


Q: Why does the official document mention Monitoring during Statol use?

Monitoring, which often involves blood tests for liver enzymes and lipid levels, is mentioned in official documents for two key reasons. It helps verify that the medicine is working correctly to reduce cholesterol levels and allows for the detection of potential serious adverse effects, such as hepatic (liver) dysfunction.


Q: Are there any known interactions with herbal products?

Official product information advises caution regarding herbal remedies because some can affect how statins are metabolized by the body. Regulatory documents recommend disclosure of all herbal use to a healthcare professional.


Q: Is the purpose of Statol to cure or manage the condition?

According to official regulatory and patient information, the purpose of Statol is to manage conditions like hypercholesterolemia. It works to reduce elevated cholesterol levels but is not indicated as a cure for the underlying disease.


Q: Do men and women experience different effects from Statol?

Clinical trial data sometimes examine the effects of Statol in both male and female subjects. Some studies have noted that the observed cholesterol-lowering effect (LDL-C reduction) is similar in both men and women, though results may vary based on the specific population studied.


Q: Is Statol a relatively new drug?

The active ingredient in Statol, Atorvastatin, was first approved by the U.S. Food and Drug Administration (FDA) in 1996. This approval date classifies it as an established and well-researched medication within its therapeutic class.


Q: Is Statol a controlled substance?

No, Statol is not classified as a controlled substance by major regulatory bodies, such as the U.S. Drug Enforcement Administration (DEA). This means it is not subject to special restrictions regarding prescribing, storage, or distribution due to abuse potential.


Q: Does Statol affect fertility?

Official regulatory information, including the Summary of Product Characteristics (SmPC), states that there is no clear evidence documented to suggest that taking Statol will negatively affect fertility in either men or women.

How should Statol be stored and disposed of?

How to Store and Dispose of Statol (Atorvastatin Calcium)

The official storage conditions for Statol tablets require maintaining controlled room temperature, specifically 20 C to 25 C (68 F to 77 F). The product must be protected from moisture and stored away from excess heat. Keep the medication in the original container, ensure it is tightly closed, and place it out of the sight and reach of children.

Disposal Requirements

Official labeling states that Statol must not be disposed of via wastewater or general household trash. Unused or expired medication must be returned to a pharmacist or a designated collection point, following local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Statol found in:

A-Z Index: